Aranda Pharma Ltd

Finnish preclinical-stage pharmaceutical company founded in 2015. Develops novel non-steroidal small molecule inhibitors of the androgen receptor. Lead product: ADA-308, candidate for treating androgenetic alopecia and acne, topically applied with no systemic effects. Also shows efficacy against prostate cancer. Based in Kuopio.